Studies on the phase I metabolites of the new designer drug 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidine-1-yl)butan-1-one (5-PPDI) in human urine
Ayumu Ishii, Kosuke Kusakabe, Noriyuki Kato, Shin-ichi Sasaki, Kenji Tsujikawa, Takeshi Wada
Topics & Concepts
PyrrolidineChemistryMetaboliteDesigner drugUrineHydroxylationDiastereomerChromatographySolid phase extractionStereoselectivityHigh-performance liquid chromatographyStereochemistryDrugOrganic chemistryBiochemistryPharmacologyMedicineEnzymeCatalysisForensic Toxicology and Drug AnalysisAlcohol Consumption and Health EffectsPsychedelics and Drug Studies